TABLE 3.
A: T2D | B: MS | C: non‐DM, non‐MS | P | P | |
---|---|---|---|---|---|
(n = 19) | (n = 19) | (n = 69) | A vs B | A vs C | |
HbA1c (%) | 8.31 ± 1.90 | 5.17 ± 0.29 | 4.96 ± 0.29 | <.0001 | <.0001 |
IRI (μU/mL) | 24.3 ± 2.73 | 22.0 ± 2.73 | 17.3 ± 1.43 | NS | NS |
UA (mg/dL) | 6.9 ± 2.0 | 6.8 ± 1.9 | 5.48 ± 1.4 | NS | .0003 |
ALT (IU/L) | 89.1 ± 63.9 | 56.3 ± 52.1 | 34.8 ± 33.5 | NS | <.05 |
ALT ≧ 35 (IU/L) | 16 (84.2%) | 9 (47.4%) | 17 (24.6%) | <.05 | <.0001 |
ALT/AST > 1 | 19 (100%) | 14 (73.4%) | 32 (46.4%) | NS | <.0001 |
Leptin (ng/mL) | 15.2 ± 14.0 | 16.02 ± 6.97 | 17.88 ± 8.13 | NS | NS |
Adiponectin (µg/mL) | 4.65 ± 1.92 | 7.35 ± 3.27 | 8.32 ± 2.71 | <.05 | <.0001 |
Family history (%) | 15 (79.0%) | 9 (47.4%) | 22 (31.9%) | <.05 | <.05 |